Bleakley Financial Group LLC Invests $1.51 Million in SPDR S&P China ETF $GXC

Bleakley Financial Group LLC bought a new stake in SPDR S&P China ETF (NYSEARCA:GXC) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 16,208 shares of the company’s stock, valued at approximately $1,509,000. Bleakley Financial Group LLC owned 0.32% of SPDR S&P China ETF at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Qube Research & Technologies Ltd boosted its stake in SPDR S&P China ETF by 136.1% during the 2nd quarter. Qube Research & Technologies Ltd now owns 491 shares of the company’s stock worth $43,000 after purchasing an additional 283 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in SPDR S&P China ETF in the fourth quarter valued at $84,000. Harbour Investments Inc. acquired a new position in SPDR S&P China ETF in the fourth quarter valued at $99,000. IAG Wealth Partners LLC raised its holdings in shares of SPDR S&P China ETF by 117.6% in the fourth quarter. IAG Wealth Partners LLC now owns 1,064 shares of the company’s stock valued at $103,000 after buying an additional 575 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of SPDR S&P China ETF in the second quarter valued at about $122,000.

SPDR S&P China ETF Stock Performance

Shares of GXC opened at $89.59 on Friday. SPDR S&P China ETF has a fifty-two week low of $85.03 and a fifty-two week high of $107.01. The firm has a 50-day simple moving average of $91.20 and a 200-day simple moving average of $95.50. The company has a market capitalization of $452.43 million, a price-to-earnings ratio of 12.97 and a beta of 0.35.

SPDR S&P China ETF Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors. The Index is float adjusted, meaning that only those shares publicly available to investors are included in the Index calculation. The Fund uses a passive management strategy designed to track the price and yield performance of the Index.